Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 8/20 | 0.49 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.37 |
| ▸ | METAP2 | P50579 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6318847 | 1.00 | GHSR (0.49) | GHSRHRH4METAP2MMP9 | |
| SCHEMBL6319716 | 1.00 | GHSR (0.49) | GHSRHRH4METAP2MMP9 | |
| SCHEMBL7979458 | 1.00 | GHSR (0.49) | GHSRHRH4METAP2MMP9 | |
| SCHEMBL6320106 | 1.00 | GHSR (0.49) | GHSRHRH4METAP2MMP9 | |
| SCHEMBL6316681 | 0.92 | GHSR (0.49) | GHSRMMP9 | |
| SCHEMBL6325138 | 0.92 | GHSR (0.49) | GHSRMMP9 | |
| SCHEMBL6316698 | 0.92 | GHSR (0.49) | GHSRMMP9 | |
| SCHEMBL6325135 | 0.92 | GHSR (0.49) | GHSRMMP9 | |
| SCHEMBL6320802 | 0.92 | GHSR (0.59) | GHSRMMP9 | |
| SCHEMBL6323451 | 0.92 | GHSR (0.59) | GHSRMMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3765658-B1 | ELECTROPLATED PRODUCTS AND ELECTROPLATING BATH FOR PROVIDING SUCH PRODUCTS | COVENTYA S P A (IT) | 2023-06-14 | — | — | EP | claimed |
| US-11142826-B2 | Substitution-type electroless gold plating solution containing purine or pyrimidine-based compound having carbonyl oxygen and substitution-type electroless gold plating method using the same | MK CHEM & TECH CO., LTD (KR) | 2021-10-12 | — | — | US | claimed |
| EP-3765658-A1 | ELECTROPLATED PRODUCTS AND ELECTROPLATING BATH FOR PROVIDING SUCH PRODUCTS | COVENTYA S.p.A. (IT) | 2021-01-20 | — | — | EP | claimed |
| US-20200095685-A1 | SUBSTITUTION-TYPE ELECTROLESS GOLD PLATING SOLUTION CONTAINING PURINE OR PYRIMIDINE-BASED COMPOUND HAVING CARBONYL OXYGEN AND SUBSTITUTION-TYPE ELECTROLESS GOLD PLATING METHOD USING THE SAME | MK CHEM & TECH CO., LTD (KR) | 2020-03-26 | — | — | US | claimed |
| EP-3540097-A1 | ELECTROPLATED PRODUCTS AND ELECTROPLATING BATH FOR PROVIDING SUCH PRODUCTS | COVENTYA S.p.A. (IT) | 2019-09-18 | — | — | EP | claimed |
| US-20030055261-A1 | Compounds with growth hormone releasing properties | HELSINN THERAPEUTICS (U.S.), INC. | 2003-03-20 | — | — | US | claimed |
| US-20030040483-A1 | Compounds with growth hormone releasing properties | HELSINN THERAPEUTICS (U.S.), INC. | 2003-02-27 | — | — | US | claimed |
| US-6194032-B1 | ELECTROLESS PLATING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2001-02-27 | — | — | US | claimed |
| US-5977178-A | Compounds with growth hormone releasing properties | NOVO NORDISK A/S (DK) | 1999-11-02 | — | — | US | claimed |
| WO-1999018255-A1 | SELECTIVE SUBSTRATE METALLIZATION | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1999-04-15 | — | — | WO | claimed |
| EP-0869974-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1998-10-14 | — | — | EP | claimed |
| WO-1997023508-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1997-07-03 | — | — | WO | claimed |
| US-5006208-A | Galvanic gold alloying bath | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1991-04-09 | — | — | US | claimed |
| JP-2054773-A | — | — | None | — | — | JP | disclosed |
| JP-2070084-A | — | — | None | — | — | JP | disclosed |
| JP-2054774-A | — | — | None | — | — | JP | disclosed |
| US-4426442-A | Method of producing metal images or patterns on and/or below the surface of a substrate comprising a semiconducting light-sensitive compound | U.S. PHILIPS CORPORATION (US) | 1984-01-17 | — | — | US | disclosed |
| EP-0094711-A1 | Method of manufacturing finely structured metal patterns on metal or semiconductor surfaces | Koninklijke Philips Electronics N.V. (NL) | 1983-11-23 | — | — | EP | disclosed |
| EP-0070061-A1 | A solution for the electroless deposition of gold-alloys onto a substrate | Koninklijke Philips Electronics N.V. (NL) | 1983-01-19 | — | — | EP | disclosed |
| US-4274926-A | ALKALI METAL THIOCYANATE, OXIDATION RESISTANCE | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1981-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055261-A1 | Compounds with growth hormone releasing properties | GHRHR, GHSR, IGFBP1 | GHSR 2/4885HRH4 1267/4885METAP2 1489/4885 |
| US-20030040483-A1 | Compounds with growth hormone releasing properties | GHRHR, GHSR, GRPR | GHSR 2/4885HRH4 976/4885METAP2 1495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.